Insys Therapeutics is having a bad run. The Arizona-based pharmaceutical company’s stock is down 50 percent from its peak in August. In that time, sales have slumped by tens of millions of dollars—and ...
As reported by the Associated Press, the CEO of INSYS Therapeutics (NASDAQ: INSY) has been accused of giving doctors kickbacks to prescribe opioids. Not surprising at all, coming from a company that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results